Forced degradation studies of rapamycin: identification of autoxidation products

J Pharm Biomed Anal. 2012 Feb 5:59:194-200. doi: 10.1016/j.jpba.2011.10.017. Epub 2011 Oct 21.

Abstract

The immunosuppressant drug rapamycin, also known as Sirolimus, underwent autoxidation under mild conditions to give numerous monomeric and oligomeric compounds, which were generally characterized by size-exclusion chromatography and NP-HPLC with UV and MS detection. Some of the more predominant products, epoxides and ketones, were isolated and identified. Two epoxides and 10S-epimer of rapamycin were described for the first time. Observed rapamycin isomers were also addressed. Computational chemistry was used to provide mechanistic insights. Formation of the majority of the rapamycin products could be rationalized with free radical-mediated autoxidation reactions involving alkene and alcohol sites. Methodological aspects of oxidative stress testing are discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatography, Gel
  • Chromatography, High Pressure Liquid
  • Chromatography, Reverse-Phase
  • Dimerization
  • Drug Stability
  • Epoxy Compounds / isolation & purification*
  • Immunosuppressive Agents / analysis*
  • Immunosuppressive Agents / chemistry
  • Isomerism
  • Ketones / isolation & purification*
  • Mass Spectrometry
  • Molecular Structure
  • Oxidation-Reduction
  • Sirolimus / analysis*
  • Sirolimus / chemistry

Substances

  • Epoxy Compounds
  • Immunosuppressive Agents
  • Ketones
  • Sirolimus